ALFA FinderBSE filing, NSE: MAFATIND. Summary written from the filing by ALFA Finder's alert engine.
Mafatlal Industries Ltd: key numbers
- Share price
- ₹108.90
- Market cap
- ₹783.1 Cr
- Revenue (annual)
- ₹3,871 Cr
- Net profit (annual)
- ₹89.98 Cr
- P/E (TTM)
- 16.3×Sector 48.4×
- Promoter holding
- 69.30%+0.00% QoQ
- FII holding
- 0.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mafatlal Industries Ltd
All →Mafatlal Industries Acquisition Worth ₹0.25 Cr
Mafatlal Industries' board approved buying a 20% stake in its subsidiary PSPL from an existing shareholder for Rs. 25 lakh. The company's holding rises from 60% to 80%.
- Value
- ₹0.25 Cr
- Execution
- Within thirty (30) days
Mafatlal Industries Investor Presentation: Key Takeaways
Q2FY27 revenue fell 22.9% YoY to INR 794.1 Cr, PAT INR 11.0 Cr (-50.3%), operating EBITDA margin 1.8%. Uniforms and Digital Infrastructure revenue rose 24.6% to INR 540 Cr; order book INR 575 Cr.
Mafatlal Industries Dividend
Mafatlal Industries declared an interim dividend of Re 1.00 per equity share for FY2026-27. Record date is 13 November 2026, with payment by 27 November 2026.
Mafatlal Industries Management Change
Mafatlal Industries redesignated Mr. Hrishikesh Arvind Mafatlal from Executive Director to Non-Executive Non-Independent Director, effective 4 November 2026. The change requires shareholder approval through postal ballot.
Mafatlal Industries Q2 FY27 Results: Net Profit ₹10.7 Cr, Down 50.2% YoY
Mafatlal Industries Ltd reported revenue from operations of ₹794.6 Cr (-22.8% YoY) and net profit of ₹10.7 Cr (-50.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹10.7 Cr · -50.2% YoY
Mafatlal Industries Board Meeting Date
Mafatlal Industries updated that its 4 November 2026 board meeting will consider an interim dividend for FY27. Record date, if approved, is 13 November 2026.
Other business update announcements
All →Cohance Lifesciences Business Update
Cohance Lifesciences disclosed that USFDA issued the Establishment Inspection Report for its Pashamylaram facility, classifying the inspection as Voluntary Action Indicated. The inspection is now concluded.
Religare Enterprises Business Update
Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.
Purple Wave Infocom Business Update
Purple Wave signed a 5-year data integration agreement with BPCL for its Hygiair devices. The Rs 10 crore figure is indicative, not firm order value.
- Execution
- 5 years
Msafe Equipments Business Update
MSAFE Equipments announced a Dhanteras puja at its upcoming Mathura integrated manufacturing facility, expected to commence operations by May 2027. The release describes planned capacity expansion but reports no contract, order, or financial value.
Skyways Air Services Business Update
Skyways Air Services renewed its Global Annual Agreement with Qatar Airways for one year. The agreement's size is not quantifiable, so no value is assigned.
- From
- Qatar Airways Group Q.C.S.C.
- Execution
- 1 year from effective date 1 January 2026
Zydus Lifesciences Business Update
Zydus Lifesciences' subsidiary presented Phase 2b trial data for investigational saroglitazar in MASH at AASLD 2026. The drug showed higher steatohepatitis resolution than placebo, but its safety and effectiveness for this use are not yet established.